“PCTL is positioned for explosive growth. PCTL has some category-creating technology that can impact the world. We are looking forward to being a strategic partner with PCTL to continue to deliver and develop strategy, attract intellectual capital and develop the marketing and branding need, to let the world see what we see,” stated Mike Sims, Krag CEO.
Gary Grieco, CEO of PCT states, “It’s a rare occurrence when a company like PCT can secure a private placement above the current market price for its shares. It is also rare to find an individual like Mr. Sims, who can look beyond the current situation and structure of the company and price his investment with a long-term view of the growth and profitability his investment brings.”
This strikes me as the most major piece of non-toxic financing in the company's history, with a very well-established, legit firm that has now made a major vote of confidence in the company's products.
There are 20+ new generation machines now in play for already-committed customers.
I think we're getting very close to LIFT-OFF here. So glad I loaded up in the .008-.009 range a while back
I wonder what the conversion rate of preferred to commons will be?
The private placement consisted of 1,500,000 shares of Convertible Preferred Stock, at $1.50 per share. The Preferred shares are convertible to common stock at $0.015 per share.
This investment was committed to above the open market trading price. The proceeds are being used to make a significant impact on PCTL’s debt as well as purchasing materials to build twenty second generation hospital units and five second generation large volume units.
After performing extensive due diligence with a Dallas based marketing, branding and business advising firm, Mike Sims, CEO of Krag Capital was lead investor in a $2,250,000 private placement of PCTL’s Series C Convertible Preferred Stock (“Preferred Stock”).
Krag Capital has become a strategic partner and through its affiliation with The Edge, will assist PCT in marketing and branding.